Funding for this research was provided by:
Jacques und Gloria Gossweiler-Stiftung (N/A)
The Welsh Government through Health and Care Research Wales, Health Fellowship Award (HF-16-1152)
Received: 11 December 2019
Accepted: 24 May 2020
First Online: 19 June 2020
Ethics approval and consent to participate
: A favourable ethical opinion for this study was given by Wales Research Ethics Committee (REC) 1 reference number 16/WA/0322 on 2 December 2016.
: Not applicable.
: Hannah Furby was employed at Cardiff University during data collection, but became an employee of F. Hoffmann La Roche, Ltd. on 8 Jan 2019. Roche has a drug for HD in clinical development. The other authors have no competing interests to declare.